Translation Abundance | Transforming Medicine Through Better Trials

Across labs and systems, the pattern never changed: ideas are abundant; translation is starved. Results are locked in PDFs; methods live as prose; data sits behind permissions; incentives reward novelty over reuse. We need an open artifact graph—runnable protocols, minimal datasets, baselines, and provenance—that anyone can pull like a library and re‑run like code Nature survey: >70% couldn't reproduce others ↗ FAIR ↗ protocols.io ↗ HF Hub ↗ . The good news: science is getting programmable. Protocol packages, standardized data models, cloud/testbed APIs, and agentic tools mean experiments can be expressed, executed, and audited like software. Translation is where these pieces meet the real world. We rebuild the pathways: standards; platform trials and testbeds; single‑review with modern consent; minimal datasets; telemetry‑first oversight; real‑world endpoints; open provenance; equity by design. Upstream discovery is exploding; downstream deployment crawls. We're at the starting line—c

Across labs and systems, the pattern never changed: ideas are abundant; translation is starved. Results are locked in PDFs; methods live as prose; data sits behind permissions; incentives reward novelty over reuse. We need an open artifact graph—runnable protocols, minimal datasets, baselines, and provenance—that anyone can pull like a library and re‑run like code Nature survey: >70% couldn't reproduce others ↗ FAIR ↗ protocols.io ↗ HF Hub ↗ . The good news: science is getting programmable. Protocol packages, standardized data models, cloud/testbed APIs, and agentic tools mean experiments can